Editors

 

Editor-in-Chief:

Fred H. Menko
Family Cancer Clinic, Antoni van Leeuwenhoek/ Netherlands Cancer Institute, Amsterdam, The Netherlands

Hans F.A. Vasen
The Netherlands Foundation for the Detection of Hereditary Tumours, Leiden University Medical Center, The Netherlands

Associate Editor:

D.T. Bishop
St. James's University Hospital, Leeds, UK

C. R. Boland
University of California San Diego, La Jolla, CA, USA

J.E. Garber
Dana-Farber Cancer Institute, Boston, MA, USA

S. Narod
Womens College Research Institute, Toronto,ON, Canada

I. Tomlinson
University of Oxford, UK

Editorial Board Members:

L. A. Aaltonen, Helsinki, Finland; I. Blanco, Barcelona, Spain; J. Burn, Newcastle upon Tyne, UK; G. Capellá, L'Hospitalet de Llobregat, Spain; F. Carneiro, Porto, PortugalA. de la Chapelle, Columbus, OH, USA; P. Devilee, Leiden, The Netherlands; D.F. Easton, Cambridge, UK; R. Eeles, London, UK; D.G.R. Evans, Manchester, UK; D.E. Goldgar, Lyon, France; H. Hampel, Columbus, OH, USA; S. Hodgson, London, UK; A. Latchford, London, UK; K. H. Lu, Houston, TX, USA; P. Lynch, Houston, TX, USAF. Macrae, Victoria, Australia; E. Maher, Cambridge, UK; J.-P. Mecklin, Jyväskylä, Finland; B. Meiser, Randwick NSW AustraliaP. Møller, Oslo, Norway; G. Moslein, Witten, Germany; M.A. Rodriguez-Bigas, Houston, TX, USA; L. Schmidt, Bethesda, MD,USA; S. Syngal, Boston, MA, USA; G. D. Valk, Utrecht, The Netherlands; B.L. Weber, Philadelphia, PA, USA